# Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence

> **NCT00749658** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 121 (actual)

## Conditions studied

- Nicotine Dependence
- Nicotine Withdrawal

## Interventions

- **DRUG:** Bupropion
- **DRUG:** Varenicline

## Key facts

- **NCT ID:** NCT00749658
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2020-11-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00749658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00749658, "Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00749658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*